Stop by booth #622 to learn more about the Foundation and our programs including, Innovation in Medical Evidence Development and Surveillance (IMEDS), the Expanded Access Navigator, and our Fellowship initiative.

Please attend our session #359, in Room 253C Wednesday, June 27, 2:00 --3:15 pm, “IMEDS: A Collaboration Based on the FDA’s Sentinel Initiative.” Our CEO June Wasser MA will be joined for a panel discussion by Jeffrey Brown PhD, MA, Harvard Pilgrim Health Care Institute /Harvard Medical School, Cheryl Walraven PhD, Director Informatics, Aetna, and Claudia Salinas, PhD, Senior Research Scientist, GPS Pharmacoepidemiology, Eli Lilly and Company. Learn from our IMEDS partners about the use of claims data and the opportunity for companies to sponsor studies on important drug safety questions.

The Reagan-Udall Foundation team looks forward to speaking with you!